Pharma-Bio Serv (PBSV) Expected to Announce Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) is anticipated to release its earnings data on Monday, January 27th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share and revenue of $4,000.00 billion for the quarter.

Pharma-Bio Serv Trading Down 0.3 %

PBSV opened at $0.58 on Friday. Pharma-Bio Serv has a 1-year low of $0.31 and a 1-year high of $1.08. The firm has a 50-day moving average price of $0.53 and a two-hundred day moving average price of $0.58. The stock has a market capitalization of $13.34 million, a PE ratio of -19.37 and a beta of 0.51.

About Pharma-Bio Serv

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Read More

Earnings History for Pharma-Bio Serv (OTCMKTS:PBSV)

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.